A treatment for fatal lung diseases such as idiopathic pulmonary fibrosis is being ... such as cardiac fibrosis and scleroderma. The company was co-founded in 2013 by Steven Idell and Andrew ...

idiopathic pulmonary fibrosis, and scleroderma. The company is exploring strategic options including out-licensing for its two programs in fibrosis. The LOXL2 enzyme increases the cross-linking of ...

However, if properly screened and approved for LT, patients with SSc experience similar rates of survival 2 years after the procedure compared with patients who receive LT for pulmonary fibrosis ...

Additionally, scleroderma renal crisis and pulmonary hypertension lead to significant ... factor beta act together to promote sustained fibrosis. Thus the constitutive overexpression of connective ...

Patients showed no difference in skin fibrosis whether they were given low-dose oral glucocorticoids or not. One patient in each treatment group had scleroderma renal crisis. Low doses of ...

Systemic scleroderma, also known simply as scleroderma, is a chronic connective tissue disease characterized by progressive ...

Current epidemiology and treatment practices for pulmonary sarcoidosis in the U.S. based on real-world evidence ...